BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang HJ, Jiang JH, Yang YT, Guo Z, Li JJ, Liu XH, Lu F, Zeng FH, Ye JS, Zhang KL, Chen NZ, Xiang BD, Li LQ. Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection. Tumour Biol 2017;39:1010428317695944. [PMID: 28351330 DOI: 10.1177/1010428317695944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Ge C, Luo M, Guo K, Zhu D, Han N, Wang T, Zhao X. Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: a large-scale real-world study. iLIVER 2022. [DOI: 10.1016/j.iliver.2022.11.003] [Reference Citation Analysis]
2 Zhang X, Svn Z, Liv M, Liu M, Zhang Y, Sun Q. Assessment of Prognostic Value of Aspartate Aminotransferase-to-Platelet Ratio Index in Patients With Hepatocellular Carcinoma: Meta-Analysis of 28 Cohort Studies. Front Med (Lausanne) 2021;8:756210. [PMID: 34901068 DOI: 10.3389/fmed.2021.756210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Salama M, Nomir M, Fahmi M, El-gayar A, El-shishtawy M. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma. Sci Pharm 2018;86:44. [DOI: 10.3390/scipharm86040044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Zhang Y, Zhang X. Prognostic value of aspartate aminotransferase to platelet ratio index as a noninvasive biomarker in patients with hepatocellular carcinoma: a meta-analysis. Cancer Manag Res 2018;10:3023-32. [PMID: 30214297 DOI: 10.2147/CMAR.S174095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Yang YT, Jiang JH, Yang HJ, Wu ZJ, Xiao ZM, Xiang BD. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Sci Rep 2018;8:2535. [PMID: 29416061 DOI: 10.1038/s41598-018-20199-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]